Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TSHR | P16473 | 1/20 | 0.35 |
| ▸ | THRB | P10828 | 1/20 | 0.35 |
| ▸ | FDPS | P14324 | 11/20 | 0.33 |
| ▸ | GGPS1 | O95749 | 7/20 | 0.33 |
| ▸ | SMPD1 | P17405 | 3/20 | 0.33 |
| ▸ | MEN1 | O00255 | 1/20 | 0.32 |
| ▸ | MAPT | P10636 | 1/20 | 0.32 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.32 |
| ▸ | ATM | Q13315 | 1/20 | 0.32 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.32 |
| ▸ | CES2 | O00748 | 1/20 | 0.31 |
| ▸ | LPAR1 | Q92633 | 1/20 | 0.31 |
| ▸ | LPAR3 | Q9UBY5 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL22903085 | 0.97 | TSHR (0.40) | TSHRTHRBFDPSGGPS1SMPD1 | |
| SCHEMBL20067922 | 0.97 | TSHR (0.40) | TSHRTHRBFDPSGGPS1SMPD1 | |
| SCHEMBL28312159 | 0.97 | TSHR (0.40) | TSHRTHRBFDPSGGPS1SMPD1 | |
| SCHEMBL21472951 | 0.97 | TSHR (0.40) | TSHRTHRBFDPSGGPS1SMPD1 | |
| SCHEMBL22903055 | 0.97 | TSHR (0.40) | TSHRTHRBFDPSGGPS1SMPD1 | |
| SCHEMBL15373224 | 0.97 | TSHR (0.40) | TSHRTHRBFDPSGGPS1SMPD1 | |
| SCHEMBL6721146 | 0.92 | TSHR (0.32) | TSHRTHRBFDPS | |
| SCHEMBL21202088 | 0.92 | ALDH1A1 (0.32) | TSHR | |
| SCHEMBL22349342 | 0.85 | FAAH (0.45) | MEN1MAPTKMT2AATMLPAR3 | |
| SCHEMBL13825811 | 0.82 | ADRB2 (0.36) | TSHRTHRBFDPSGGPS1SMPD1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2012091154-A1 | METHOD OF PRODUCING A HYDROLYZABLE SILICON-CONTAINING COMPOUND | WASEDA UNIVERSITY (JP) | 2012-07-05 | — | — | WO | disclosed |
| WO-2008153967-A1 | BK1 ANTAGONIST CONJUGATES | CONTEC THERAPEUTICS, INC. (US) | 2008-12-18 | — | — | WO | disclosed |
| US-4504688-A | Process for the preparation of pure alkyl tert-alkyl ethers and hydrocarbon raffinates which are largely free from isoolefins and from alkanols | EC ERDOLCHEMIE GMBH (DE) | 1985-03-12 | — | — | US | disclosed |
| US-4376094-A | Method of disinfecting and a method for destroying bacteria and fungi using 2-substituted glutaraldehydes | STERLING DRUG INC. (US) | 1983-03-08 | — | — | US | disclosed |
| EP-0068218-A1 | Process for the preparation of pure alkyl-tert.-alkyl ethers and hydrocarbonaceous raffinates freed for the major part from isoolefines and alkanols | BAYER AG (DE) | 1983-01-05 | — | — | EP | disclosed |